Tramadol Hydrochloride
- All
- News
-
Aurobindo Pharma May Launch Tramadol Tablets in US Market
According to a statement issue by the company, it received final approval from the US Food and Drug Administration (USFDA) to manufacture and market the drug.
-
Wockhardt says Himachal Pradesh drug regulator suspends product
The state's drug controller suspended the manufacture, sale or distribution of fixed dose combination of Dicyclomine Hydrochloride IP 10mg, Tramadol Hydrochloride IP 50mg and Acetamenophen IP 325mg, the company said in a statement on Wednesday.
-
Lupin receives USFDA approval for chronic pain drug
Drug maker Lupin on Wednesday said it has received approval from the US health regulator to market Tramadol Hydrochloride Extended Release Tablets, used to treat chronic pain in adults, in the American market. The company's subsidiary Lupin Pharmaceuticals Inc has received approval from US Food and Drug Administration (USFDA) for its abbrevi...
-
Aurobindo Pharma May Launch Tramadol Tablets in US Market
According to a statement issue by the company, it received final approval from the US Food and Drug Administration (USFDA) to manufacture and market the drug.
-
Wockhardt says Himachal Pradesh drug regulator suspends product
The state's drug controller suspended the manufacture, sale or distribution of fixed dose combination of Dicyclomine Hydrochloride IP 10mg, Tramadol Hydrochloride IP 50mg and Acetamenophen IP 325mg, the company said in a statement on Wednesday.
-
Lupin receives USFDA approval for chronic pain drug
Drug maker Lupin on Wednesday said it has received approval from the US health regulator to market Tramadol Hydrochloride Extended Release Tablets, used to treat chronic pain in adults, in the American market. The company's subsidiary Lupin Pharmaceuticals Inc has received approval from US Food and Drug Administration (USFDA) for its abbrevi...
